期刊文献+

两种磺胺嘧啶锌配合物的合成、晶体结构和荧光性质(英文) 被引量:5

Syntheses, Crystal Structures and Fluorescent Spectra of Two Zn(Ⅱ) Complexes with Sulfonamide Pyrimidine
在线阅读 下载PDF
导出
摘要 以磺胺嘧啶为配体,合成了两种新的Zn(Ⅱ)配合物[Zn(L)2(bpy)](1)and{[Zn(L)2(bpp)]}n(2)(L=磺胺嘧啶,bpy=2,2′-吡啶,bpp=1,3-二(4-吡啶基)丙烷)。并对其进行了单晶X-射线衍射,粉末X-射线衍射,元素分析,热分析,红外光谱,紫外光谱和荧光光谱测定。单晶X-射线分析表明化合物1是单核结构,属三斜晶系,P1空间群,Zn(Ⅱ)是四方锥配位结构。化合物2是一维结构,属单斜晶系,P21空间群,Zn(Ⅱ)是四面体配位结构。热分析表明化合物1和2都有很高的热稳定性。 Two new Zn(Ⅱ) compounds, [Zn(L)2(bpy)] (1) and {[Zn(L)2(bpp)]}n (2) (L=sulfonamide pyrimidine, bpy=2,2'-bipyridine, bpp=1,3-bis(4-pyridyl)propane), have been synthesized and characterized by single crystal X-ray diffraction, powder X-ray diffraction (PXRD), thermal analysis, elemental analysis, IR, UV-Vis and fluorescence. Single crystal X-ray analysis reveals that complex 1 is a mononuclear structure and the Zn(Ⅱ) ion exhibits a tetragonal pyramidal coordination geometry. Complex 2 is a one-dimensional structure and the Zn(Ⅱ) ion is a tetrahedral coordination geometry. Thermal analyses show that complex 1 and 2 have high thermal stability. CCDC: 935049, 1; 935050, 2.
出处 《无机化学学报》 SCIE CAS CSCD 北大核心 2014年第3期633-639,共7页 Chinese Journal of Inorganic Chemistry
基金 中国国家自然科学基金(No.20971075 61078055) 浙江省自然科学基金(No.LY12B01005) 结构化学国家重点实验室(No.20110010) 宁波大学王宽诚幸福基金资助
关键词 磺胺嘧啶 Zn(Ⅱ)配合物 晶体结构 荧光性质 sulfonamide pyrimidine Zn(Ⅱ) complex crystal structure fluorescence
  • 相关文献

参考文献34

  • 1Sun D F, Cao R, Sun Y Q, et al. Inorg. Chem., 2003,42: 7512-7518.
  • 2Li X, Wei D Y, Huang S J, et al. J. Solid State Chem., 2009, 182:95-101.
  • 3Kremer E, Facchin G, Estévez E, et al. J. Inorg. Biochem., 2006,100:1167-1175.
  • 4Supuran C T, Casini A, Scozzafava A, et al. Curr. Cancer Drug Targets, 2002,2:55-75.
  • 5Owa T, Nagasu T. Exp. Opin. Ther. Patents, 2000,10:1725-1740.
  • 6Supuran C T, Scozzafava A. Exp. Opin. Ther. Patents, 2000, 10:575-600.
  • 7Supuran C T, Scozzafava A. Curr. Med. Chem. Immunol. Endocrinol. Metab. Agents, 2001,1:61-97.
  • 8Lobb K L, Hipskind P A, Aikins J A, et al. J. Med. Chem., 2004,47:5367-5380.
  • 9Medina J C, Roche D, Shan B, et al. Bioorg. Med. Chem. Lett., 1999,9:1843-1846.
  • 10Ajibade P A, Kolawole G A, O'Brien P, et al. Inorg. Chim. Acta, 2006,359:3111-3116.

二级参考文献4

  • 1Yuan R X, Xiong R G, Chen Z F, et al. Source: J. Chem.Soc. Dalton Trans., 2001:774-776
  • 2Guo Z, Sadler P J. Angew. Chem., Int. Ed., 1999,39:1512-1531
  • 3Ye Q, Wang X S, Zhao H, et al. Chem. Soc. Rev., 2005,34:208-225
  • 4(a)Xiong R G, You X Z, Abrahams B F, et al. Angew. Chem.Int. Ed., 2001,40:4422-4425(b)Xiong R G, Xue X, Zhao H, et al. Angew. Chem. Int. Ed.,2002,41:3800-3803(c)Xue X, Wang X S, Wang L Z, et al. Inorg. Chem., 2002,41:6544-6546

共引文献5

同被引文献92

  • 1宋词,沃艳,王冠军.磺胺嘧啶锌配合物的合成研究[J].佳木斯医学院学报,1994,17(3):46-47. 被引量:2
  • 2Jiang J, Yu J, Corma A. Angew. Chem. Int. Ed., 2010,49: 3120-3145.
  • 3Lee L W, Vittal J J. Chem. Rev., 2011,111:688-764.
  • 4Deng Z P, Huo L H, Li M S, et al. Cryst. Growth Des., 2011, 11:3090-3100.
  • 5Zhang Z Y, Deng Z P, Huo L H, et al. Inorg. Chem., 2013, 52:5914-5923.
  • 6Li J R, Ma Y G, Mcarthy M C, et al. Coord. Chem. Rev., 2011,255:1791-1823.
  • 7Feng R, Jiang F L, Chen L, et al. Chem. Commun., 2009: 5296-5298.
  • 8Murugavel R, Baheti K, Anantharaman G. Inorg. Chem., 2001,40:6870-6878.
  • 9Yu J H, Yao R, Yuan L M, et al. Inorg. Chim. Acta, 2011, 376:222-229.
  • 10Bu Y, Jiang F L, Zhang S Q, et al. CrystEngComm, 2011, 13:6323-6326.

引证文献5

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部